These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 443744)

  • 41. [Radiocompetitive dosage of 25 hydroxyvitamin D and 24, 25-dihydroxyvitamin D in geriatrics. Study of seasonal variations].
    Prier A; Camus JP; Guillemant S; Grumbach R; Kremer R
    Rev Rhum Mal Osteoartic; 1979 Oct; 46(10):517-21. PubMed ID: 545663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Low 25-hydroxy-vitamin D (25-OH-D) plasma levels in pathology (author's transl)].
    Arlet P; Dubrocq R; Duffaut M; Gaillemin C; Botreau Y; Le Tallec Y
    Sem Hop; 1980 Jun 8-15; 56(21-24):1038-41. PubMed ID: 6248981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative study of chromatographic and non-chromatographic procedures in the assay of serum 25-hydroxyvitamin D.
    Loré F; Di Cairano G; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):323-7. PubMed ID: 7248092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low levels of serum calcium, phosphorus and plasma 25-hydroxy vitamin D in cirrhosis of the liver.
    Meyer MS; Wexler S; Jedvab M; Spirer Z; Keysar N; Shibolet S
    Isr J Med Sci; 1978 Jul; 14(7):725-30. PubMed ID: 681162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A competitive protein-binding assay for 25-hydroxyvitamin D.
    Pettifor JM; Ross FP; Wang J
    Clin Sci Mol Med; 1976 Dec; 51(6):605-7. PubMed ID: 1070425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A simplified competitive protein-binding assay for 25-hydroxycalciferol.
    Garcia-Pascual B; Peytremann A; Courvoisier B; Lawson DE
    Clin Chim Acta; 1976 Apr; 68(2):99-105. PubMed ID: 177234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.
    Kaplan MM; Goldberg MJ; Matloff DS; Neer RM; Goodman DB
    Gastroenterology; 1981 Oct; 81(4):681-5. PubMed ID: 6973499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Plasma cortisol assay. Radiocompetitive assay of cortisol without chromatography (author's transl)].
    Jolivet A
    Ann Endocrinol (Paris); 1974; 35(3):223-9. PubMed ID: 4463782
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of age on the conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 by kidney of rat.
    Armbrecht HJ; Zenser TV; Davis BB
    J Clin Invest; 1980 Nov; 66(5):1118-23. PubMed ID: 6893596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma 1,25-Dihydroxyvitamin D and the Risk of Developing Hypertension: The Prevention of Renal and Vascular End-Stage Disease Study.
    van Ballegooijen AJ; Gansevoort RT; Lambers-Heerspink HJ; de Zeeuw D; Visser M; Brouwer IA; Kema IP; de Borst MH; Bakker SJ; Joosten MM
    Hypertension; 2015 Sep; 66(3):563-70. PubMed ID: 26195480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Methods and results of the determination of 25-OH-vitamin D3 in competitive protein binding assay (author's transl)].
    Offermann G
    MMW Munch Med Wochenschr; 1974 Sep; 116(37):1569-72. PubMed ID: 4141056
    [No Abstract]   [Full Text] [Related]  

  • 52. Serum 25-hydroxyvitamin D assay. Evalution of chromatographic and non-chromatographic procedures.
    Skinner RK; Wills MR
    Clin Chim Acta; 1977 Nov; 80(3):543-54. PubMed ID: 912921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Competitive protein binding assay for 24,25-dihydroxycholecalciferol.
    Taylor CM; Hughes SE; de Silva P
    Biochem Biophys Res Commun; 1976 Jun; 70(4):1243-9. PubMed ID: 942442
    [No Abstract]   [Full Text] [Related]  

  • 54. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum 25-hydroxycholecalciferol in Greek uremics.
    Drivas G; Bamias J; Tsomis A; Kalos A; Douratsos D; Melissinos K
    Invest Urol; 1980 Jul; 18(1):52-3. PubMed ID: 7410014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Absence of seasonal variation in serum concentrations of 1,25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer.
    Chesney RW; Rosen JF; Hamstra AJ; Smith C; Mahaffey K; DeLuca HF
    J Clin Endocrinol Metab; 1981 Jul; 53(1):139-42. PubMed ID: 6972382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An improved competitive protein-binding assay for 25-hydroxy vitamin D.
    Aksnes L
    Scand J Clin Lab Invest; 1978 Nov; 38(7):677-86. PubMed ID: 715370
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease.
    Doorenbos CR; de Cuba MM; Vogt L; Kema IP; van den Born J; Gans RO; Navis G; de Borst MH
    J Steroid Biochem Mol Biol; 2012 Jan; 128(1-2):56-61. PubMed ID: 21958677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A competitive protein binding assay for plasma 25-hydroxyvitamin D3 in normal children.
    Shimotsuji T; Seino Y; Yabuuchi H
    Tohoku J Exp Med; 1976 Mar; 118(3):233-40. PubMed ID: 1265740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assay of plasma 25-hydroxy vitamin D.
    Morris JF; Peacock M
    Clin Chim Acta; 1976 Nov; 72(3):383-91. PubMed ID: 975590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.